Advanced search
Publication Cover
Psychiatry and Clinical Psychopharmacology Volume 29, 2019 - Issue 2
Journal homepage
1,027
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Auxiliary role of D5 dopamine receptor as a marker in paranoid schizophrenia patients

Mahkameh Soleiman MeygooniDepartment of Biology, North-Tehran branch, Islamic Azad University, Tehran, Iran
,
Mohammad Amin Minaei AsilDepartment of Biology, North-Tehran branch, Islamic Azad University, Tehran, Iran
,
Geghani Taroyan HaftvaniDepartment of Biology, North-Tehran branch, Islamic Azad University, Tehran, Iran
,
Firouzeh MorshedzadehDepartment of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, IranCorrespondence[email protected]
&
Davood ZaeifiDepartment of Biology, North-Tehran branch, Islamic Azad University, Tehran, Iran;Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, IranCorrespondence[email protected]
[email protected]
Pages 158-161 | Received 07 Oct 2018, Accepted 24 Jan 2019, Published online: 15 Feb 2019

References

  • Ropper AH, Joshua Klein MAS. Schizophrenia, delusional and paranoid states Adams and Victor's principles of neurology. 10th ed. New York: McGraw-Hill Education; 2014.
  • Morrison AK. Cognitive behavior therapy for people with schizophrenia. Psychiatry (Edgmont). 2009;6(12):32–39.
  • DSM-V. Diagnostic and statistical manual of mental disorders: fifth edition. Arlington (VA): American Psychiatric Publishing; 2013.
  • Aricioglu F, Ozkartal CS, Unal G, et al. Neuroinflammation in schizophrenia: a critical review and the future. Klinik Psikofarmakol Bülteni Bull Clin Psychopharmacol. 2016;26(4):429–437. doi: 10.5455/bcp.20161123044657
  • Beaulieu JM, Espinoza S, Gainetdinov RR. Dopamine receptors - IUPHAR Review 13. Br J Pharmacol. 2015;172(1):1–23. doi: 10.1111/bph.12906
  • Kose S, Cetin M. The research domain criteria framework: transitioning from dimensional systems to integrating neuroscience and psychopathology. Psychiatry Clin Psychopharmacol. 2017;27(1):1–5. doi: 10.1080/24750573.2017.1293255
  • Gingrich JA, Caron MG. Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci. 1993;16:299–321. doi: 10.1146/annurev.ne.16.030193.001503
  • Hartman DS, Lanau F. Diversity of dopamine receptors: new molecular and pharmacological developments. Pol J Pharmacol. 1997;49(4):191–199.
  • Civelli O, Bunzow JR, Grandy DK. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol. 1993;33:281–307. doi: 10.1146/annurev.pa.33.040193.001433
  • Kulkarni SK, Ninan I. Current concepts in the molecular diversity and pharmacology of dopamine receptors. Methods Find Exp Clin Pharmacol. 1996;18(9):599–613.
  • Chio CL, Lajiness ME, Huff RM. Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. Mol Pharmacol. 1994;45(1):51–60.
  • Robertson GS, Fibiger HC. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 1992;46(2):315–328. doi: 10.1016/0306-4522(92)90054-6
  • Vyas A, Khan M. Paranoid personality disorder. Am J Psychiatry Resid J. 2016;11(1):9–11. doi: 10.1176/appi.ajp-rj.2016.110103
  • Ahmadian S, Delavari G, Ghanbari D, et al. D3 as a possible marker based on D1-D4 dopamine receptors expression in paranoid schizophrenia patients. J Mol Biomark Diagn. 2014;5(3):171. doi: 10.4172/2155-9929.1000171
  • Amenta F, El-Assouad D, Mignini F, et al. Neurotransmitter receptor expression by peripheral mononuclear cells: possible marker of neuronal damage by exposure to radiations. Cell Mol Biol (Noisy-le-grand). 2002;48(4):415–421.
  • Kwak YT, Koo MS, Choi CH, et al. Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Med Genet. 2001;2:3. doi: 10.1186/1471-2350-2-3
  • Ilani T, Ben-Shachar D, Strous RD, et al. A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc Natl Acad Sci U S A. 2001;98(2):625–628. DOI:10.1073/pnas.021535398 doi: 10.1073/pnas.98.2.625
  • Lipska BK, Lerman DN, Khaing ZZ, et al. Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs. Eur J Neurosci. 2003;18(2):391–402. doi: 10.1046/j.1460-9568.2003.02738.x
  • Zhao Y, Ding M, Pang H, et al. Relationship between genetic polymorphisms in the DRD5 gene and paranoid schizophrenia in northern Han Chinese. Genet Mol Res. 2014;13(1):1609–1618. doi: 10.4238/2014.March.12.13

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.